IMV
Dartmouth
About IMV
IMV is a clinical-stage immuno-oncology company that wants to transform the way they engage human immunity to address some of the most complex, devastating diseases in today’s medical landscape.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $88.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2022)
- Ticker: nasdaq:IMV
- Website: imv-inc.com
- Phone: +1 (902) 492-1819
Industries & Categories
Biotechnology, Health Care, Oncology
Social Profiles
Canonical: https://fsome.com/organization/imv-179024 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.